Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology

BACKGROUND: The development of novel antitumor agents and accompanying biomarkers has improved survival across several tumor types. Previously, we published provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors. Recently, effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Naito, Yoichi, Mishima, Saori, Akagi, Kiwamu, Igarashi, Ataru, Ikeda, Masafumi, Okano, Susumu, Kato, Shunsuke, Takano, Tadao, Tsuchihara, Katsuya, Terashima, Keita, Nishihara, Hiroshi, Nishiyama, Hiroyki, Hiyama, Eiso, Hirasawa, Akira, Hosoi, Hajime, Maeda, Osamu, Yatabe, Yasushi, Okamoto, Wataru, Ono, Shigeru, Kajiyama, Hiroaki, Nagashima, Fumio, Hatanaka, Yutaka, Miyachi, Mitsuru, Kodera, Yasuhiro, Yoshino, Takayuki, Taniguchi, Hiroya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046581/
https://www.ncbi.nlm.nih.gov/pubmed/31974683
http://dx.doi.org/10.1007/s10147-019-01610-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046581/
https://www.ncbi.nlm.nih.gov/pubmed/31974683
http://dx.doi.org/10.1007/s10147-019-01610-y

Ejemplares similares